遺伝子治療の世界市場:ベクター種類別(ウイルスベクター、非ウイルスベクター)、遺伝子種類別(抗原、サイトカイン、腫瘍抑制因子、自殺、欠乏、成長因子、受容体、その他)、用途別(腫瘍性疾患、希少疾患、心血管疾患、神経疾患、感染症、その他)...市場調査レポートについてご紹介

【英文タイトル】Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Other Diseases): Global Opportunity Analysis and Industry Forecast, 2019–2026



▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Chapter 1: Introduction

1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

2.1. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope
3.2. Key Findings

3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies

3.3. Top Player Positioning, 2018
3.4. Porter’S Five Forces Analysis
3.5. Market Dynamics

3.5.1. Drivers

3.5.1.1. High Investment For R&D Activities Pertaining To Gene Therapy
3.5.1.2. Increase In Prevalence of Cancer
3.5.1.3. Growth In Awareness Regarding Gene Therapy

3.5.2. Restraints

3.5.2.1. High Cost Associated With Gene Therapies
3.5.2.2. Unwanted Immune Responses

3.5.3. Opportunities

3.5.3.1. Untapped Potential For Emerging Markets

Chapter 4: Gene Therapy Market, By Vector Type

4.1. Overview

4.1.1. Market Size And Forecast

4.2. Viral Vectors

4.2.1. Key Market Trends, Growth Factors, And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Size And Forecast, By Type
4.2.4. Market Size And Forecast, By Country
4.2.5. Adenovirus
4.2.6. Lentivirus
4.2.7. Retrovirus
4.2.8. Adeno-Associated Virus
4.2.9. Herpes Simplex Virus
4.2.10. Poxvirus
4.2.11. Vaccinia Virus
4.2.12. Others

4.3. Non-Viral Techniques

4.3.1. Key Market Trends, Growth Factors, And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Size And Forecast, By Type
4.3.4. Market Size And Forecast, By Country
4.3.5. Naked Plasmid Vector
4.3.6. Gene Gun
4.3.7. Electroporation
4.3.8. Lipofection
4.3.9. Others

Chapter 5: Gene Therapy Market, By Gene Type

5.1. Overview

5.1.1. Market Size And Forecast, Type

5.2. Antigen

5.2.1. Market Size And Forecast
5.2.2. Market Size And Forecast, By Country

5.3. Cytokine

5.3.1. Market Size And Forecast
5.3.2. Market Size And Forecast, By Country

5.4. Tumor Suppressor

5.4.1. Market Size And Forecast, By Region
5.4.2. Market Size And Forecast, By Country

5.5. Suicide Gene

5.5.1. Market Size And Forecast
5.5.2. Market Size And Forecast, By Country

5.6. Deficiency

5.6.1. Market Size And Forecast, By Region
5.6.2. Market Size And Forecast, By Country

5.7. Growth Factors

5.7.1. Market Size And Forecast, By Region
5.7.2. Market Size And Forecast, By Country

5.8. Receptors

5.8.1. Market Size And Forecast, By Region
5.8.2. Market Size And Forecast, By Country

5.9. Others

5.9.1. Market Size And Forecast, By Region
5.9.2. Market Size And Forecast, By Country

Chapter 6: Gene Therapy Market, By Application

6.1. Overview

6.1.1. Market Size And Forecast, By Application

6.2. Oncological Disorders

6.2.1. Market Size And Forecast, By Region
6.2.2. Market Size And Forecast, By Country

6.3. Rare Diseases

6.3.1. Market Size And Forecast, By Region
6.3.2. Market Size And Forecast, By Country

6.4. Cardiovascular Diseases

6.4.1. Market Size And Forecast, By Region
6.4.2. Market Size And Forecast, By Country

6.5. Neurological Disorders

6.5.1. Market Size And Forecast
6.5.2. Market Size And Forecast, By Country

6.6. Infectious Diseases

6.6.1. Market Size And Forecast, By Region
6.6.2. Market Size And Forecast, By Country

6.7. Other Diseases

6.7.1. Market Size And Forecast
6.7.2. Market Size And Forecast, By Country

Chapter 7: Gene Therapy Market, By Region

7.1. Overview

7.1.1. Market Size And Forecast

7.2. North America

7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. Market Size And Forecast, By Country
7.2.3. Market Size And Forecast, By Vector Type
7.2.4. Market Size And Forecast, By Gene Type
7.2.5. Market Size And Forecast, By Application

7.2.5.1. U.S. Market Size And Forecast, By Vector Type
7.2.5.2. U.S. Market Size And Forecast, By Gene Type
7.2.5.3. U.S. Market Size And Forecast, By Application
7.2.5.4. Canada Market Size And Forecast, By Vector Type
7.2.5.5. Canada Market Size And Forecast, By Gene Type
7.2.5.6. Canada Market Size And Forecast, By Application
7.2.5.7. Mexico Market Size And Forecast, By Vector Type
7.2.5.8. Mexico Market Size And Forecast, By Gene Type
7.2.5.9. Mexico Market Size And Forecast, By Application

7.3. Europe

7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Market Size And Forecast, By Country
7.3.3. Market Size And Forecast, By Vector Type
7.3.4. Market Size And Forecast, By Gene Type
7.3.5. Market Size And Forecast, By Application

7.3.5.1. Germany Market Size And Forecast, By Vector Type
7.3.5.2. Germany Market Size And Forecast, By Gene Type
7.3.5.3. Germany Market Size And Forecast, By Application
7.3.5.4. France Market Size And Forecast, By Vector Type
7.3.5.5. France Market Size And Forecast, By Gene Type
7.3.5.6. France Market Size And Forecast, By Application
7.3.5.7. Uk Market Size And Forecast, By Vector Type
7.3.5.8. Uk Market Size And Forecast, By Gene Type
7.3.5.9. Uk Market Size And Forecast, By Application
7.3.5.10. Italy Market Size And Forecast, By Vector Type
7.3.5.11. Italy Market Size And Forecast, By Gene Type
7.3.5.12. Italy Market Size And Forecast, By Application
7.3.5.13. Spain Market Size And Forecast, By Vector Type
7.3.5.14. Spain Market Size And Forecast, By Gene Type
7.3.5.15. Spain Market Size And Forecast, By Application
7.3.5.16. Rest of Europe Market Size And Forecast, By Vector Type
7.3.5.17. Rest of Europe Market Size And Forecast, By Gene Type
7.3.5.18. Rest of Europe Market Size And Forecast, By Application

7.4. Asia-Pacific

7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Market Size And Forecast, By Country
7.4.3. Market Size And Forecast, By Vector Type
7.4.4. Market Size And Forecast, By Gene Type
7.4.5. Market Size And Forecast, By Application

7.4.5.1. Japan Market Size And Forecast, By Vector Type
7.4.5.2. Japan Market Size And Forecast, By Gene Type
7.4.5.3. Japan Market Size And Forecast, By Application
7.4.5.4. China Market Size And Forecast, By Vector Type
7.4.5.5. China Market Size And Forecast, By Gene Type
7.4.5.6. China Market Size And Forecast, By Application
7.4.5.7. India Market Size And Forecast, By Vector Type
7.4.5.8. India Market Size And Forecast, By Gene Type
7.4.5.9. India Market Size And Forecast, By Application
7.4.5.10. South Korea Market Size And Forecast, By Vector Type
7.4.5.11. South Korea Market Size And Forecast, By Gene Type
7.4.5.12. South Korea Market Size And Forecast, By Application
7.4.5.13. Rest of Asia-Pacific Market Size And Forecast, By Vector Type
7.4.5.14. Rest of Asia-Pacific Market Size And Forecast, By Gene Type
7.4.5.15. Rest of Asia-Pacific Market Size And Forecast, By Application

7.5. Lamea

7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Market Size And Forecast, By Country
7.5.3. Market Size And Forecast, By Vector Type
7.5.4. Market Size And Forecast, By Gene Type
7.5.5. Market Size And Forecast, By Application

7.5.5.1. Brazil Market Size And Forecast, By Vector Type
7.5.5.2. Brazil Market Size And Forecast, By Gene Type
7.5.5.3. Brazil Market Size And Forecast, By Application
7.5.5.4. South Africa Market Size And Forecast, By Vector Type
7.5.5.5. South Africa Market Size And Forecast, By Gene Type
7.5.5.6. South Africa Market Size And Forecast, By Application
7.5.5.7. Rest of Lamea Market Size And Forecast, By Vector Type
7.5.5.8. Rest of Lamea Market Size And Forecast, By Gene Type
7.5.5.9. Rest of Lamea Market Size And Forecast, By Application

Chapter 8: Company Profile

8.1. Adaptimmune Therapeutics Plc.

8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.1.6. Key Strategic Moves And Developments

8.2. Anchiano Therapeutics Ltd.

8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio

8.3. Achieve Life Sciences, Inc.

8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Key Strategic Moves And Developments

8.4. Adverum Biotechnologies, Inc.

8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Key Strategic Moves And Developments

8.5. Abeona Therapeutics Inc.

8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance
8.5.6. Key Strategic Moves And Developments

8.6. Applied Genetic Technologies Corporation

8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance
8.6.6. Key Strategic Moves And Developments

8.7. Arbutus Biopharma Corporation

8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Product Portfolio
8.7.4. Business Performance
8.7.5. Key Strategic Moves And Developments

8.8. Audentes Therapeutics Inc.

8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Product Portfolio
8.8.4. Key Strategic Moves And Developments

8.9. Avexis Inc.

8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Product Portfolio
8.9.4. Key Strategic Moves And Developments

8.10. Bluebird Bio, Inc.

8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
8.10.6. Key Strategic Moves And Developments

8.11. Celgene Corporation

8.11.1. Company Overview
8.11.2. Company Snapshot
8.11.3. Operating Business Segments
8.11.4. Product Portfolio
8.11.5. Business Performance
8.11.6. Key Strategic Moves And Developments

8.12. Crispr Therapeutics Ag

8.12.1. Company Overview
8.12.2. Company Snapshot
8.12.3. Product Portfolio
8.12.4. Business Performance
8.12.5. Key Strategic Moves And Developments

8.13. Editas Medicine, Inc.

8.13.1. Company Overview
8.13.2. Company Snapshot
8.13.3. Operating Business Segments
8.13.4. Product Portfolio
8.13.5. Business Performance
8.13.6. Key Strategic Moves And Developments

8.14. Gilead Sciences, Inc.

8.14.1. Company Overview
8.14.2. Company Snapshot
8.14.3. Operating Business Segments
8.14.4. Product Portfolio
8.14.5. Business Performance
8.14.6. Key Strategic Moves And Developments

8.15. Glaxosmithkline Plc

8.15.1. Company Overview
8.15.2. Company Snapshot
8.15.3. Operating Business Segments
8.15.4. Product Portfolio
8.15.5. Business Performance
8.15.6. Key Strategic Moves And Developments

8.16. Intellia Therapeutics Inc.

8.16.1. Company Overview
8.16.2. Company Snapshot
8.16.3. Operating Business Segments
8.16.4. Product Portfolio
8.16.5. Business Performance
8.16.6. Key Strategic Moves And Developments

8.17. Merck & Co., Inc.

8.17.1. Company Overview
8.17.2. Company Snapshot
8.17.3. Operating Business Segments
8.17.4. Product Portfolio
8.17.5. Business Performance
8.17.6. Key Strategic Moves And Developments

8.18. Novartis Ag

8.18.1. Company Overview
8.18.2. Company Snapshot
8.18.3. Operating Business Segments
8.18.4. Product Portfolio
8.18.5. Business Performance
8.18.6. Key Strategic Moves And Developments

8.19. Regenxbio, Inc.

8.19.1. Company Overview
8.19.2. Company Snapshot
8.19.3. Product Portfolio
8.19.4. Business Performance
8.19.5. Key Strategic Moves And Developments

8.20. Spark Therapeutics, Inc.

8.20.1. Company Overview
8.20.2. Company Snapshot
8.20.3. Operating Business Segments
8.20.4. Product Portfolio
8.20.5. Business Performance
8.20.6. Key Strategic Moves And Developments

8.21. Sangamo Therapeutics, Inc.

8.21.1. Company Overview
8.21.2. Company Snapshot
8.21.3. Operating Business Segments
8.21.4. Product Portfolio
8.21.5. Business Performance
8.21.6. Key Strategic Moves And Developments

8.22. Uniqure N. V.

8.22.1. Company Overview
8.22.2. Company Snapshot
8.22.3. Operation Segments
8.22.4. Product Portfolio
8.22.5. Business Performance
8.22.6. Key Strategic Moves And Developments

8.23. Voyager Therapeutics, Inc.

8.23.1. Company Overview
8.23.2. Company Snapshot
8.23.3. Operating Business Segments
8.23.4. Product Portfolio
8.23.5. Business Performance
8.23.6. Key Strategic Moves And Developments


【レポート販売概要】

■ タイトル:遺伝子治療の世界市場:ベクター種類別(ウイルスベクター、非ウイルスベクター)、遺伝子種類別(抗原、サイトカイン、腫瘍抑制因子、自殺、欠乏、成長因子、受容体、その他)、用途別(腫瘍性疾患、希少疾患、心血管疾患、神経疾患、感染症、その他)
■ 英文:Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Other Diseases): Global Opportunity Analysis and Industry Forecast, 2019–2026


■ 発行日:2019年12月31日
■ 調査会社:Allied Market Research
■ 商品コード:AMR20FE041
■ 調査対象地域:グローバル
  • データ品質管理ツールの世界市場2015-2019
    About Data Quality Tools Data quality tools refer to the wide range of tools required for ensuring quality and reliability of data in various business processes including core business operations, BI, analytics, and decision making. The data quality vendors offer a wide range of functionalities including data profiling, monitoring, parsing, standardization, and data enrichment. These tools are app …
  • 米国のバイオ燃料産業:Biofuel Industry in the United States
    Biofuels are liquid, solid, or gaseous fuels derived from renewable biological sources. Biomass can be burned directly for thermal energy or converted to other high-value energy sources including ethanol, biodiesel, methanol, hydrogen, or methane. Currently, ethanol from corn grain and biodiesel are the only biofuels produced in the United States on an industrial scale. Most of the four billion ga …
  • オーストラリアのバイオ燃料産業分析:Analyzing the Biofuel Industry in Australia
    Although biofuels are mainly used to replace or supplement the traditional petroleum-based transportation fuels, they can also be deployed to generate heat and electricity. Being an alternative to fossils, biofuels can be applied to existing vehicles with little or no engine modification. Although they release CO2 when burned in internal combustion engines, they differ from fossil fuels partly bec …
  • 2014年戦略提言:Mononucleosis診断検査市場
    The report presents a detailed analysis of the Mononucleosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Mononucleosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:     - Hospitals    &nbs …
  • ポリグリコール酸の世界市場予測:フォーム別、エンドユーズ産業別
    “The growth in polyglycolic acid demand is majorly driven by its huge consumption in the medical industry, particularly in the absorbable surgical suture segment.”The polyglycolic acid market size is estimated to be USD 4.1 billion in 2019 and is projected to reach USD 6.5 billion by 2024, at a CAGR of 9.5%. The rapidly developing and growing demand for polyglycolic acid in the medical industry, i …
  • 世界の駐車管理市場:駐車管理ソフトウェア、パーキングメーター、車両検知センサー、監視カメラ、駐車料金管理など
    The world is moving towards intelligent transportation systems, which is broadening the space for smarter ways of parking. With advanced parking management systems, the parking spots operators can offer their customers various parking conveniences such as minimal time wastage, cashless and contactless payment options, enhanced vehicle security, and options for pre-booking parking spots. The parkin …
  • 世界の高性能コンピューティング市場予測及び分析
    High-Performance Computing (HPC) delivers high performance by aggregation of several computing nodes coupled together to solve large complex problems in science, engineering, and businesses. Typically, HPC machine comprises of several components such as processors, memory disk, operating system, and various software to boost the performance of the entire machine. The performance of these computing …
  • 建設管理ソフトウェアの世界市場2016-2020
    About the Construction Management Software Market Construction management software is used to plan, collaborate, and manage construction projects. The software helps contractors to estimate the budget and define the scope of the project and the desired outcome before project commencement. It provides an overview of the required labor and helps develop effective communication during times of confli …
  • 無人陸上車両(UGV)の世界市場2015-2019
    About UGVs UGVs are majorly used in the Defense sector for examining the terrain, supplying ammunition to the soldiers during a combat situation, carrying out rescue operations during disasters, and for detecting explosives. They are used in the areas and situations that are hazardous and dangerous to humans. They have sensors to observe the environment and terrain and provide data and images of t …
  • Quicksilver Resources Inc.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    Quicksilver Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Quicksilver Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
  • World Insecticides Market Dynamics and Trends 2014: Strategic Assessments of Leading Suppliers
    This new report from Venture Planning Group analyzes marketing strategies of the world’s leading agrochemical companies. The report was prepared by Venture Planning Group to provide agrochemical industry executives with strategically significant competitor information, analysis and insight, critical to the development and implementation of effective marketing and R&D programs. In a highl …
  • フェノキシ樹脂の世界市場
    Phenoxy Resin (CAS 26402-79-9) Market Research Report 2013 presents comprehensive data on Phenoxy resin markets globally and regionally (Europe, Asia, North America etc.) The Phenoxy Resin (CAS 26402-79-9) Market Research Report 2013 includes Phenoxy resin description, covers its application areas and related patterns. It overviews Phenoxy resin market, names Phenoxy resin producers and indicates …
  • 2014 Assessments of Leading Coagulation Market Players–Strategic Analyses of Major Suppliers and Emerging Market Entrants
    This new report from Venture Planning Group provides strategic assessments of major coagulation product suppliers and emerging market entrants. The report presents analyses of major manufacturers of coagulation products in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. …
  • 自動車用コラプシブルステアリングコラムの世界市場2017-2021
    About Automotive Collapsible Steering ColumnCollapsible steering column consists of two hollow shafts with the smaller shaft placed inside the other. The two shafts are fitted into each other with the help of bearings and sealing. This design structure allows the steering column to collapse during a frontal impact and absorbs the energy of impact. Technavio’s analysts forecast the global automotiv …
  • 化粧品成分の世界市場2017-2021:軟化剤、皮膜形成剤、モイスチャー、界面活性剤、単用添加剤、キャリア、パウダー、着色剤、増粘剤
    About Cosmetic Ingredients Cosmetic ingredients form the base chemicals for personal care products, which include soaps, shampoos, lotions, perfumes, and a variety of other products. Some cosmetics are not only used for beauty regimes, but they also serve as vital components of wellbeing. Some examples of vital cosmetics are toothpaste and sunscreens. Historically, there had been several amendment …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。